$2.80
-0.03[-1.06%]
Last update: 9:08AM Get Real Time Here
Bio-Path Hldgs
(NASDAQ:BPTH)Bio-Path Hldgs Stock (NASDAQ:BPTH), Quotes and News Summary
Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
| Open | $2.770 |
| Close | - |
| Volume / Avg. | 18.850K / 1.405M |
| Day Range | 2.666 - 2.796 |
| 52 Wk Range | 2.350 - 44.800 |
| Market Cap | $4.383M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 36 |
| Short Interest | 4.31% |
| Days to Cover | 1.92 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Path Hldgs (BPTH) stock?
You can purchase shares of Bio-Path Hldgs (NASDAQ: BPTH) through any online brokerage.
Who are Bio-Path Hldgs's (BPTH) competitors?
Other companies in Bio-Path Hldgs’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
What is the target price for Bio-Path Hldgs (BPTH) stock?
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by Roth MKM on Thursday, April 18, 2024. The analyst firm set a price target for 40.00 expecting BPTH to rise to within 12 months (a possible 1400.66% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Bio-Path Hldgs (BPTH)?
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $2.6655 last updated Today at May 1, 2024 at 10:12 AM EDT.
Does Bio-Path Hldgs (BPTH) pay a dividend?
There are no upcoming dividends for Bio-Path Hldgs.
When is Bio-Path Hldgs (NASDAQ:BPTH) reporting earnings?
Bio-Path Hldgs’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
Is Bio-Path Hldgs (BPTH) going to split?
There is no upcoming split for Bio-Path Hldgs.
What sector and industry does Bio-Path Hldgs (BPTH) operate in?
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.